Study: Drugs reprogram genes in breast tumors to prevent endocrine resistance

IMAGE: University of Illinois food science and human nutrition professor and her team found in a new study that targeting estrogen receptor-positive breast tumors with the XPO1 antagonist selinexor and the… view more  CHAMPAIGN, Ill. — Treating breast tumors with two cancer drugs simultaneously may prevent endocrine resistance by attacking the disease along two separate gene…

Details